2,6-Diaryl Pyridazinones With Immunosuppressant Activity
US patent 5,506,228
Press Enter · cited answer in seconds
0 sources
2,6-Diaryl Pyridazinones With Immunosuppressant Activity
Summary
2,6-Diaryl Pyridazinones With Immunosuppressant Activity is a patent[1].
Key Facts
- 2,6-Diaryl Pyridazinones With Immunosuppressant Activity is credited with the discovery of Richard Arthur Norton[2].
- 2,6-Diaryl Pyridazinones With Immunosuppressant Activity's image is recorded as United States patent 5506228.png[3].
- 2,6-Diaryl Pyridazinones With Immunosuppressant Activity's instance of is recorded as patent[4].
- 2,6-Diaryl Pyridazinones With Immunosuppressant Activity's publication date is recorded as +1996-04-09T00:00:00Z[5].
- 2,6-Diaryl Pyridazinones With Immunosuppressant Activity's main subject is recorded as immunosuppressive drug[6].
- 2,6-Diaryl Pyridazinones With Immunosuppressant Activity's patent number is recorded as US5506228[7].
- 2,6-Diaryl Pyridazinones With Immunosuppressant Activity's different from is recorded as Method For Inhibiting Activation Of The Human A3 Adenosine Receptor To Treat Asthma[8].
- 2,6-Diaryl Pyridazinones With Immunosuppressant Activity's author name string is recorded as Richard Arthur Norton[9].
- 2,6-Diaryl Pyridazinones With Immunosuppressant Activity's author name string is recorded as Mohammed K. A. Ibraham[10].
- 2,6-Diaryl Pyridazinones With Immunosuppressant Activity's quotation or excerpt is recorded as A class of 2,6-diarylpyridazinones of general structural formula I have been identified that exhibit exhibit immunosuppressant activity with human T-lymphocytes, and are useful as an immunosuppressants or a pharmaceutically acceptable salt, hydrate or crystal form thereof, wherein: when M is S, R1 and R2 are selected from the following combinations: when R2 is 4-chloro, then R1 is 4-OCH3,2-CH3, 4-Cl, 4-CH3, 3-Cl, 3-CH3, 2-Cl, 4-H, 4-Br, 3-NO2; and when R2 is H, then R1 is 4-OCH3, and when M is -SO2-, then R2 is H and R1 is 4-OCH3. As an immunosuppressant, these compounds are useful in the treatment of autoimmune diseases, the prevention of rejection of foreign organ transplants and/or related afflictions, diseases and illnesses.[11].
- 2,6-Diaryl Pyridazinones With Immunosuppressant Activity's Lens ID is recorded as 055-401-238-954-959[12].
Body
Designation and Status
2,6-Diaryl Pyridazinones With Immunosuppressant Activity's instance of is recorded as patent[4].